Xia Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xia Huang has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Hongke Hao
Department of Biosciences and Bioinformatics
3 shared publicationsJiayi Wan
Department of Biosciences and Bioinformatics
2 shared publicationsYiheng Liu
Department of Biosciences and Bioinformatics
2 shared publications- Bincan Deng
Sino‐Spain Joint Laboratory on Biomedical Materials (S2LBM) College of Materials Science and Engineering Nanjing Tech University Nanjing China
1 shared publication Bingxin Liu
1 shared publication- Bo Chen
Institute of Materials Science and Devices, School of Materials Science and Engineering, Suzhou University of Science and Technology, Suzhou, China
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (9) , 5519-5532
Inhibition of VEGF 165 -Induced Angiogenesis by Gold Nanoparticles through HQGQH as the Primary Binding Site
Inhibition of vascular endothelial growth factor 165 (VEGF165)-mediated angiogenesis is a promising anticancer strategy. While gold nanoparticles (AuNPs) are effective inhibitors of VEGF165, the precise molecular interface of their interactions with VEGF165 is unclear, hindering rational therapeutic design. This study combined molecular dynamics (MD) simulations and experimental techniques to map the binding interface between AuNPs and VEGF165. We discovered that AuNPs preferentially bind to the HQGQH motif on VEGF165. Functional assays showed that this binding inhibited VEGF165-induced endothelial cell migration and angiogenesis. The necessity of the HQGQH motif was unequivocally demonstrated by mutagenesis. A 5A-substituted VEGF165 mutant exhibited markedly reduced AuNP binding affinity across binding free energy calculations, ELISA, and ζ potential measurements, and its angiogenic activity became resistant to AuNP inhibition to some extent. These findings reveal the molecular basis of AuNP-mediated VEGF165 blockade, opening avenues for designing targeted antiangiogenic nanomedicines.
- 17 April 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (9) , 5519-5532
Open AccessInhibition of VEGF 165 -Induced Angiogenesis by Gold Nanoparticles through HQGQH as the Primary Binding Site
Inhibition of vascular endothelial growth factor 165 (VEGF165)-mediated angiogenesis is a promising anticancer strategy. While gold nanoparticles (AuNPs) are effective inhibitors of VEGF165, the precise molecular interface of their interactions with VEGF165 is unclear, hindering rational therapeutic design. This study combined molecular dynamics (MD) simulations and experimental techniques to map the binding interface between AuNPs and VEGF165. We discovered that AuNPs preferentially bind to the HQGQH motif on VEGF165. Functional assays showed that this binding inhibited VEGF165-induced endothelial cell migration and angiogenesis. The necessity of the HQGQH motif was unequivocally demonstrated by mutagenesis. A 5A-substituted VEGF165 mutant exhibited markedly reduced AuNP binding affinity across binding free energy calculations, ELISA, and ζ potential measurements, and its angiogenic activity became resistant to AuNP inhibition to some extent. These findings reveal the molecular basis of AuNP-mediated VEGF165 blockade, opening avenues for designing targeted antiangiogenic nanomedicines.
- Open Access
- 3 December 2025
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 349, 127294
Raman imaging uncovers Ebracteolatain A's subtype-selective metabolic reprogramming in luminal versus triple-negative breast cancer cells
- 3 December 2025
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 349, 127294
Open AccessRaman imaging uncovers Ebracteolatain A's subtype-selective metabolic reprogramming in luminal versus triple-negative breast cancer cells
- Open Access
- 15 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102061
Bioinspired 3D hydrogel scaffold to mimic tumor microenvironment for investigating into the anoikis resistance mechanisms in colorectal cancer
- 15 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102061
Open AccessBioinspired 3D hydrogel scaffold to mimic tumor microenvironment for investigating into the anoikis resistance mechanisms in colorectal cancer
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 27, 2288-2297
Random splicing assisted deep learning for breast cancer cell line classification via Raman spectroscopy
Raman spectroscopy extracts rich biochemical information on a single cell, demonstrating significant potential for precise cancer identification. While machine learning enhances spectral analysis efficiency, conventional models remain constrained by data volume. Here, we developed Random Splicing-Convolutional Neural Network (RS-CNN), a deep learning framework that addresses data scarcity through spectral concatenation. By randomly splicing Raman spectra from the same cell line, RS-CNN enhances distinctive spectral features while simultaneously expanding dataset size and improving signal quality. Validation across six breast cancer cell lines demonstrated RS-CNN's superiority over five benchmark models (SVM, LDA, PCA-SVM, PCA-LDA, CNN). With 450 spectra per cell line, RS-CNN achieved 98.63 % classification accuracy compared to conventional models' accuracies of around 85 %. Under data-limited conditions (100 spectra/line), RS-CNN maintained 91.47 % accuracy, outperforming CNN's 70.83 %. The RS-CNN’s generalizability was further validated by an independently acquired dataset, achieving at least 94 % classification accuracy. SHAP analysis suggested the spectral region around 980 cm⁻¹ was significant for cancer diagnosis, while the 1158–1160 cm⁻¹and 1603–1607 cm⁻¹ regions were particularly valuable for distinguishing between cancer subtypes. These findings establish RS-CNN as a robust analytical model for clinical Raman diagnostics, particularly valuable in applications requiring high accuracy with limited samples.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 27, 2288-2297
Open AccessRandom splicing assisted deep learning for breast cancer cell line classification via Raman spectroscopy
Raman spectroscopy extracts rich biochemical information on a single cell, demonstrating significant potential for precise cancer identification. While machine learning enhances spectral analysis efficiency, conventional models remain constrained by data volume. Here, we developed Random Splicing-Convolutional Neural Network (RS-CNN), a deep learning framework that addresses data scarcity through spectral concatenation. By randomly splicing Raman spectra from the same cell line, RS-CNN enhances distinctive spectral features while simultaneously expanding dataset size and improving signal quality. Validation across six breast cancer cell lines demonstrated RS-CNN's superiority over five benchmark models (SVM, LDA, PCA-SVM, PCA-LDA, CNN). With 450 spectra per cell line, RS-CNN achieved 98.63 % classification accuracy compared to conventional models' accuracies of around 85 %. Under data-limited conditions (100 spectra/line), RS-CNN maintained 91.47 % accuracy, outperforming CNN's 70.83 %. The RS-CNN’s generalizability was further validated by an independently acquired dataset, achieving at least 94 % classification accuracy. SHAP analysis suggested the spectral region around 980 cm⁻¹ was significant for cancer diagnosis, while the 1158–1160 cm⁻¹and 1603–1607 cm⁻¹ regions were particularly valuable for distinguishing between cancer subtypes. These findings establish RS-CNN as a robust analytical model for clinical Raman diagnostics, particularly valuable in applications requiring high accuracy with limited samples.
- Open Access
- 19 February 2024
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 44 (2)
Excitation energy transfer in proteoliposomes reconstituted with LH2 and RC-LH1 complexes from Rhodobacter sphaeroides
Light-harvesting 2 (LH2) and reaction-centre light-harvesting 1 (RC-LH1) complexes purified from the photosynthetic bacterium Rhodobacter (Rba.) sphaeroides were reconstituted into proteoliposomes either separately, or together at three different LH2:RC-LH1 ratios, for excitation energy transfer studies. Atomic force microscopy (AFM) was used to investigate the distribution and association of the complexes within the proteoliposome membranes. Absorption and fluorescence emission spectra were similar for LH2 complexes in detergent and liposomes, indicating that reconstitution retains the structural and optical properties of the LH2 complexes.
- 19 February 2024
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 44 (2)
Open AccessExcitation energy transfer in proteoliposomes reconstituted with LH2 and RC-LH1 complexes from Rhodobacter sphaeroides
Light-harvesting 2 (LH2) and reaction-centre light-harvesting 1 (RC-LH1) complexes purified from the photosynthetic bacterium Rhodobacter (Rba.) sphaeroides were reconstituted into proteoliposomes either separately, or together at three different LH2:RC-LH1 ratios, for excitation energy transfer studies. Atomic force microscopy (AFM) was used to investigate the distribution and association of the complexes within the proteoliposome membranes. Absorption and fluorescence emission spectra were similar for LH2 complexes in detergent and liposomes, indicating that reconstitution retains the structural and optical properties of the LH2 complexes.
- Open Access
- 1 December 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 7861-7873
Layered Double Hydroxide Modified with Deoxycholic and Hyaluronic Acids for Efficient Oral Insulin Absorption
Introduction: This study aimed to construct a layered double hydroxide (LDH) nanoparticle delivery system that was modified by deoxycholic acid (DCA) and hyaluronic acid (HA) to increase the bioavailability of oral insulin. Methods: LDH-DCA-HA was synthesized by the hybridization of DCA and HA with LDH. Subsequently, insulin was loaded onto LDH-DCA-HA, resulting in the formation of [email protected] The in vivo and in vitro mechanisms of insulin release, as well as the efficiency of insulin absorption, were analyzed before and after DCA-HA modification. Results: MTT assay showed that there was satisfactory biocompatibility between LDH-DCA-HA and Caco-2 cells at a concentration below 1000 μg/mL. Flow cytometry analysis revealed that Caco-2 cells absorbed [email protected] more readily than insulin. Measurement of transepithelial electrical resistance indicated that [email protected] induced the reversible opening of tight cell junctions, thereby facilitating its absorption. This was confirmed via laser confocal microscopy analysis, revealing that a large amount of zonula occludens-1 tight junction (TJ) protein was utilized for the paracellular pathway of nanoparticles. We also measured the blood glucose levels of type I diabetic mice and found that oral [email protected] exerted a steady hypoglycemic effect lasting 12 h, with a small range of postprandial blood glucose fluctuation. Immunofluorescence analysis showed that the strong penetration ability of [email protected] allowed insulin to enter epithelial cells more readily than free insulin. Finally, immunohistochemical analysis of anti-SLC10A1 protein confirmed that the cholic acid transporter receptor protein played a key role in the functioning of [email protected] Conclusion: LDH nanoparticles modified by DCA and HA improved the absorption efficiency of insulin by opening the TJs of cells and interacting with the cholic acid transporter receptor protein.
- 1 December 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 7861-7873
Open AccessLayered Double Hydroxide Modified with Deoxycholic and Hyaluronic Acids for Efficient Oral Insulin Absorption
Introduction: This study aimed to construct a layered double hydroxide (LDH) nanoparticle delivery system that was modified by deoxycholic acid (DCA) and hyaluronic acid (HA) to increase the bioavailability of oral insulin. Methods: LDH-DCA-HA was synthesized by the hybridization of DCA and HA with LDH. Subsequently, insulin was loaded onto LDH-DCA-HA, resulting in the formation of [email protected] The in vivo and in vitro mechanisms of insulin release, as well as the efficiency of insulin absorption, were analyzed before and after DCA-HA modification. Results: MTT assay showed that there was satisfactory biocompatibility between LDH-DCA-HA and Caco-2 cells at a concentration below 1000 μg/mL. Flow cytometry analysis revealed that Caco-2 cells absorbed [email protected] more readily than insulin. Measurement of transepithelial electrical resistance indicated that [email protected] induced the reversible opening of tight cell junctions, thereby facilitating its absorption. This was confirmed via laser confocal microscopy analysis, revealing that a large amount of zonula occludens-1 tight junction (TJ) protein was utilized for the paracellular pathway of nanoparticles. We also measured the blood glucose levels of type I diabetic mice and found that oral [email protected] exerted a steady hypoglycemic effect lasting 12 h, with a small range of postprandial blood glucose fluctuation. Immunofluorescence analysis showed that the strong penetration ability of [email protected] allowed insulin to enter epithelial cells more readily than free insulin. Finally, immunohistochemical analysis of anti-SLC10A1 protein confirmed that the cholic acid transporter receptor protein played a key role in the functioning of [email protected] Conclusion: LDH nanoparticles modified by DCA and HA improved the absorption efficiency of insulin by opening the TJs of cells and interacting with the cholic acid transporter receptor protein.